DCF Advisers’s InflaRx IFRX Stock Holding History

DCF Advisers’s Portfolio IFRX Stock Details IFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$142K	Hold	158,500	–	–	0.04%	83
2025 Q4	$160K	Buy	+158,500	New	+$197K	0.04%	92

Other funds holding IFRX

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

T3 Companies New York $76.8M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

DCF Advisers's IFRX Position: Q1 2026 in Review

DCF Advisers held its InflaRx (IFRX) position steady in Q1 2026 at 158,500 shares worth $142K. The position accounts for 0.04% of the portfolio, ranked #83.

DCF Advisers first reported a position in IFRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $160K in Q4 2025. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

DCF Advisers held 158,500 shares of InflaRx worth $142K as of Q1 2026.
DCF Advisers left its InflaRx share count unchanged in Q1 2026.
InflaRx made up 0.04% of DCF Advisers's portfolio in Q1 2026, its #83 holding.
DCF Advisers first reported a position in InflaRx in Q4 2025 and has held it in 2 quarters since.
DCF Advisers's InflaRx position peaked at $160K in Q4 2025.
35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.